Wednesday, August 12, 2026 | 10:49 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Trump Pharma Tariffs: Latest News

Trump Pharma Tariffs: Latest News

US President Donald Trump on Wednesday announced a phased tariff plan for imported generic medicines, giving drugmakers a two-year window before duties begin to rise sharply.
 
Under the proposal, generic drugs imported into the US will continue to attract zero tariffs from August 1 for two years, after which the tariff will increase to 100 per cent for one year before rising further to 200 per cent in August 2029. The phased structure is intended to give pharmaceutical companies time to shift manufacturing operations to the US before punitive tariffs take effect.
 
“This is done in order to RESHORE Generic Pharmaceutical Production
...
Read More

Indian drugmakers in no rush to shift to US despite tariff threat

Indian pharma companies are expanding selectively in the US for complex products while retaining India as their manufacturing base despite Trump's tariff threat

Updated On : 03 Aug 2026 | 5:08 AM IST
Trump Pharma Tariffs

Trump's 200% tariffs on imported generic medicines to test India's edge

Imported generics to remain tariff-free for two years; industry doubts US can build a cost-competitive manufacturing ecosystem within the transition period

Updated On : 22 Jul 2026 | 11:37 PM IST
Trump Pharma Tariffs

US proposal to impose tariffs on generic medicines could impact India: GTRI

The think tank says Indian generics may remain cost-competitive despite higher tariffs, but higher-value formulations and branded generics could face greater pressure

Updated On : 22 Jul 2026 | 2:51 PM IST
Trump Pharma Tariffs

Trump's 200% tariff plan on generic drugs: What it means for India

Donald Trump has proposed phased tariffs of up to 200% on imported generic drugs by 2028 to boost US manufacturing. Here's why the move matters for India's pharma sector and bilateral trade

Updated On : 22 Jul 2026 | 12:02 PM IST
Trump Pharma Tariffs

Latest Updates on Trump Pharma Tariffs: Latest News

Dr Reddy's Labs shares tank 9% to 52-week low after Q1 show. Time to sell?

Brokerages largely remain bearish on Dr Reddy's Labs shares following the Q1 earnings show.

Dr Reddy's Labs shares tank 9% to 52-week low after Q1 show. Time to sell?
Updated On : 23 Jul 2026 | 10:59 AM IST

Glenmark, Biocon, Aurobindo slip 3% on Trump's generic drug tariff plan

The US President Donald Trump announced a proposal to impose phased tariff (up to 200%) regime on imported generic medicines aimed at encouraging pharmaceutical manufacturing within the United States.

Glenmark, Biocon, Aurobindo slip 3% on Trump's generic drug tariff plan
Updated On : 22 Jul 2026 | 10:19 AM IST

Trump set to impose fresh tariffs by July 24 with stopgap to expire

The Trump administration last month proposed new tariffs of at least 10 per cent on 60 trading partners, citing what it said were lax forced-labor standards

Trump set to impose fresh tariffs by July 24 with stopgap to expire
Updated On : 22 Jul 2026 | 7:53 AM IST

Trump announces 100% tariff on imported generic drugs from August 2028

Trump has seized on the cost of drugs as a key driver of affordability concerns ahead of the 2026 midterm elections

Trump announces 100% tariff on imported generic drugs from August 2028
Updated On : 22 Jul 2026 | 7:28 AM IST